No significant difference was observed in serum sCD30 levels between CRC patients (n = 23) and healthy subjects (n = 23, Supplementary Fig. 2), suggesting no preferential cleavage of CD30 in CRC patients following cellular activation. The gene discussed is TNFRSF8; the disease is colorectal carcinoma.